Condition: Catecholaminergic Polymorphic Ventricular Tachycardia · Sponsor: Cardurion Pharmaceuticals, Inc.
This is a Phase 2, multicenter, double-blind, sponsor blinded, placebo-controlled, repeat-dose clinical study of CRD-4730 to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CRD-4730 to participants with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT). Participants with CPVT will complete a 3-period, randomized 3-sequence study. Each participant will be randomized to one of the 3 sequences in which they will receive 2 different doses of CRD-4730 and 1 dose of matching placebo.
This description comes directly from the study's public registry record.
Cardurion · 617-863-8088 · infoCPVT@cardurion.com
Always discuss trial participation with your own doctor first.
| Cardurion Investigative Site | San Francisco, California, United States | Recruiting |
| Cardurion Investigative Site | Morrisville, North Carolina, United States | Recruiting |
| Cardurion Investigative Site | Houston, Texas, United States | Recruiting |
| Cardurion Investigative Site | Salt Lake City, Utah, United States | Recruiting |
| Cardurion Investigative Site | Madison, Wisconsin, United States | Recruiting |
| Cardurion Investigative Site | Vancouver, British Columbia, Canada | Recruiting |
| Cardurion Investigative Site | Bron, France | Recruiting |
| Cardurion Investigative Site | Paris, France | Recruiting |
| Cardurion Investigative Site | Saint-Herblain, France | Recruiting |
| Cardurion Investigative Site | Pavia, Pavia, Italy | Recruiting |
| Cardurion Investigative Site | Amsterdam, North Holland, Netherlands | Recruiting |
| Cardurion Investigative Site | Esplugues de Llobregat, Barcelona, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06658899